Together, these data suggest a heretofore unknown role for NF-κB in regulating ChREBP nuclear localization and activation, in response to high carbohydrate diet, for further explorations in lines of NAFLD therapeutics. The gene discussed is MLXIPL; the disease is metabolic dysfunction-associated steatotic liver disease.